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Lysine biosynthesis proceeds by the nucleotide-dependent reduction of dihydrodipicolinate (DHDP)
to tetrahydrodipicolinate (THDP) by dihydrodipicolinate reductase (DHDPR). The S. aureus DHDPR
structure reveals different conformational states of this enzyme even in the absence of a substrate
or nucleotide-cofactor. Despite lacking a conserved basic residue essential for NADPH interaction, S.
aureus DHDPR differs from other homologues as NADPH is a more preferred co-factor than NADH.
The structure provides a rationale-Lys35 compensates for the co-factor site mutation. These obser-
vations are signiﬁcant for bi-ligand inhibitor design that relies on ligand-induced conformational
changes as well as co-factor speciﬁcity for this important drug target.
Structured summary of protein interactions:
DHDPR binds to DHDPR by molecular sieving (View interaction).
DHDPR binds to DHDPR by dynamic light scattering (View interaction).
DHDPR binds to DHDPR by X-ray crystallography (View interaction).
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Staphylococcus aureus is a pathogen responsible for superﬁcial
infections on skin and soft tissues and severe life threatening inva-
sive infections like pneumonia, osteomyelitis, arthritis, endocardi-
tis and sepsis [1,2]. Staphylococci can rapidly acquire resistance to
several front-line antibiotics in both hospitals as well as commu-
nity settings. Antibiotic resistance in these cocci involves very
few mutations that distinguish between susceptible and the resis-
tant strains [3]. In addition to the development of methicillin resis-
tant (MRSA) strains, the recent emergence of vancomycin-resistant
strains of S. aureus (VRSA), underscores the need to characterize
novel drug targets from this evasive pathogen [4]. Enzymes of bac-
terial L-lysine/m-dap pathway are signiﬁcant in this regard as they
represent potential alternate targets that are absent in humans and
have not been exploited in the treatment of Staphylococcal infec-
tions [5,6].
Dihydrodipicolinate reductase (DHDPR), a product of an essen-
tial gene referred to as dapB, catalyzes the second step of lysine
biosynthesis. DHDPR catalyzes the reduction of 2,3-dihydrodipico-
linate (DHDP) to 2,3,4,5-tetrahydrodipicolinate (THDP) in a nucle-
otide dependent reaction [7]. THDP is the common precursor for
the biosynthesis of m-DAP/L-Lys in all characterized biosynthetic
routes viz., the succinylase, acetylase and dehydrogenase pathwayschemical Societies. Published by E
l).[8]. Recent reports, based on the characterization of the substrate
speciﬁcity of dihydrodipicolinate synthase (DHDPS) revealed that
DHDPR could also function as a dehydratase in addition to the role
of a nucleotide dependent reductase [9]. Structures of DHDPR
homologues from Escherichia coli,Mycobacterium tuberculosis, Ther-
motoga maritima and Bartonella henselae have been determined
([10,11,18]; PDB:1VM6 (Joint Centre for Structural Genomics)
and PDB:3IJP (Seattle Structural Genomics Center for Infectious
Disease). DHDPR is a homotetramer with each monomer unit con-
sisting of an N-terminal nucleotide binding (cofactor) domain and
a C-terminal substrate binding (tetramerization) domain linked by
a ﬂexible loop. The active site is located at the interface between
the nucleotide binding and substrate binding domains. Hydrogen
exchange experiments [12] and the crystal structures of DHDPR
bound to nucleotides and substrate analogues suggest that the
hydride transfer reaction requires the movement of N-terminal
domain towards the C-terminal domain [11,13].
DHDPR enzymes show large differences in their nucleotide
binding speciﬁcity. Both E. coli DHDPR (EcDHDPR) and M. tubercu-
losis DHDPR (MtDHDPR) show dual nucleotide speciﬁcity with a
preference for NADH over NADPH. The T. maritima enzyme
(TmDHDPR), on the other hand, has higher afﬁnity for NADPH over
NADH. The dual speciﬁcity of EcDHDPR and MtDHDPR enzymes
could be rationalized based on their crystal structures and
sequence analysis [11,13,14]. The dual speciﬁcity of EcDHDPR
could be attributed primarily to the interaction of Glu38 and
Arg39 with bound nucleotides. Glu38 interacts with both 20- andlsevier B.V. All rights reserved.
Table 1
Summary of data collection and reﬁnement statistics.
PDB code 3QY9
Wavelength (Å) 0.9762
Resolution (Å) 28.5–1.8 (1.9–1.8)a
Space group P212121
Unit cell dimensions a = 85.90 Å, b = 112.44 Å,
c = 131.61 Å, a = b = c = 90.0
Number of observations 798406 (97586)
Number of unique observations 115798 (15914)
Mean I/r(I) 12.7 (2.9)
Multiplicity 6.9 (6.1)
Completeness 98.0 (93.4)
Rmerge (%)b 8.6 (55.9)
Reﬁnement statistics
2562 T.S. Girish et al. / FEBS Letters 585 (2011) 2561–256730-hydroxyl groups of the adenosyl ribose of NADH, while the
adjacent Arg39 residue interacts with the 20-phosphate of NADPH
[13]. In the absence of a conserved basic residue equivalent to
Arg39, Lys9 and Lys11 were proposed to indirectly stabilize the
20-phosphate of NADPH in MtDHDPR [13]. However these residues
are not conserved across all bacteria. In fact, both Lys9 and Lys11
(MtDHDPR) and Arg39 (EcDHDPR) are not conserved in S. aureus
DHDPR (SaDHDPR). Here we report the crystal structure and bio-
chemical characterization of SaDHDPR that reveals dual speciﬁcity
for nucleotide co-factors with a preference that differs from the
E. coli and M. tuberculosis homologues. The structure of SaDHDPR
at high resolution reveals distinctive features that could be
employed for the design of inhibitors against this essential protein.Rwork (%)c 18.36
Rfree (%)d 22.15
Total number of residues 962
Total number of water molecules 744
Total number of sulfate ions 22
RMSD bond length (Å) 0.009
RMSD bond-angle () 1.18
a Values for outer shells are given in parenthesis.
b Rmerge ¼
P
j j hIi  Ij j =
PhIi where Ij is the intensity of the jth reﬂection and hIi
is the average intensity.
c Rwork ¼
P
hkl j Fo  Fc j
P
hkl j Fo j.
d Rfree was calculated as for Rwork but on 5% of the data excluded from the
reﬁnement calculation.2. Materials and methods
2.1. Cloning, expression and puriﬁcation of SaDHDPR
The dapB gene was PCR ampliﬁed from the genomic DNA of S.
aureus COL and cloned into pET expression vectors (15b and 22b).
These plasmid(s) were transformed into E. coli BL21(DE3) cells.
The expression protocol for SaDHDPR and the K35A mutant was
similar- transformed cells were grown at 37 C to an optical density
of 0.6 at 600 nm. The cells were subsequently induced with 0.5 mM
IPTG. Post induction, the cells were further grown at 21 C for 5–6 h.
The recombinant protein with a hexa-histidine tag at either the N-
or the C-terminus was puriﬁed by Ni2+-NTA afﬁnity chromatogra-
phy. In the case of the recombinant DHDPRwithout a hexa-histidine
tag, the cell-free lysate was passed through a DEAE-Sepharose col-
umn (3 ml of resin) at a ﬂow rate of 0.3 ml/min. This partially puri-
ﬁed protein was further puriﬁed by size exclusion chromatography.
2.2. Analysis of the quaternary association
An analytical size exclusion experiment was performed to
ascertain the quaternary structure of S. aureus DHDPR in solution.
About 100 ll of puriﬁed protein (2.0 mg/ml) was passed through a
Superdex S-200 (10/300 GL) column at a ﬂow rate of 0.3 ml/min
equilibrated in 25 mM Tris–HCl pH 7.5 and 200 mM NaCl. Dynamic
light scattering studies were carried out on a Dynapro Light Scat-
tering instrument (Wyatt Technology Co., USA) at 2.0 mg/ml pro-
tein concentration in a buffer containing 50 mM Tris–HCl pH 7.5
and 200 mM NaCl.
2.3. Isothermal titration calorimetry
The puriﬁed SaDHDPR and the K35A mutant proteins were
analyzed for their cofactor speciﬁcity by isothermal titration cal-
orimetry (ITC). These experiments were performed in a VP-ITC
MicroCalorimeter (MicroCal, Inc.) at 25 C. Puriﬁed SaDHDPR
samples were dialyzed against 25 mM HEPES pH 7.5 for 24 h
at 4 C prior to the ITC experiment. The sample cell (1.4 ml)
had 75 lM of protein and the syringe (volume 298 ll) contained
2 mM of the nucleotide (NADH/NADPH) solution. Titrations were
performed by a step-wise addition of 5 ll ligand solution into
the sample cell in 8 s. A time interval of 180 s between succes-
sive injections and a stirring speed of 351 rpm was maintained
throughout the titration. The data could be best ﬁtted to an
equation describing the ligand binding to a macromolecule pos-
sessing a set of independent binding sites (Origin software).
2.4. Crystallization and structure determination
Crystallization trials of SaDHDPR involved different recombi-
nant protein constructs and optimization steps (Supplementarymethods 1). Crystallization experiments with SaDHDPR without a
hexa-histidine tag yielded a single crystal in a condition containing
2.0 M ammonium sulfate and 0.2 M sodium acetate pH 4.5. Diffrac-
tion data were collected on a CCD detector with 0.5 oscillation per
image at the beam-line BM14 of the European synchrotron radia-
tion facility (ESRF). The data were processed using MOSFLM [15]
and scaled using SCALA [16]. The data collection and reﬁnement
statistics are compiled in Table 1. The molecular replacement
(MR) trials using the intact polypeptide chain of either EcDHDPR
(PDB:1ARZ) or TmDHDPR (PDB:1VM6) using PHASER [17] were
not successful. However, when two domains of EcDHDPR were
used as independent search models, an MR solution was obtained
with a log likelihood gain of 338. The model was further reﬁned
using Refmac5 with three TLS groups that were deﬁned based on
an analyses with the TLSMD server.
3. Results and discussion
3.1. Crystal structure of SaDHDPR
The crystal structure of SaDHDPR was determined at 1.8 Å res-
olution- representing the highest resolution structure of a bacterial
DHDPR. While SaDHDPR crystallized in several conditions, the res-
olution of this data was restricted due to an unusually long unit
cell axis [19]. Removal of the hexa-histidine tag from the recombi-
nant protein was crucial to obtain crystals that diffracted to high
resolution. However, despite extensive efforts, we could not obtain
crystals of the SaDHDPR-cofactor complexes. Each monomer unit
of SaDHDPR comprises of 240 residues, with an N-terminal nucle-
otide binding domain and a C-terminal substrate binding domain
connected by a hinge region. Discontinuous electron density in
the nucleotide and substrate binding cavities were interpreted as
sulfate ions as the crystallization condition contained ammonium
sulfate. In case of chain B and D, ﬂat trigonal density was modeled
as acetate as the crystallization condition also contained sodium
acetate. The four monomer units of SaDHDPR interact extensively
with an overall buried surface area of 10 890 Å2 (Fig. 1, Supplemen-
tary Table 1). The tetrameric arrangement of SaDHDPR is consis-
tent with both gel ﬁltration and dynamic light scattering studies
(Supplementary Fig. 1).
Fig. 1. Sequence and structural features of S. aureus DHDPR. (a) Structure based sequence alignment of SaDHDPR (wheat), EcDHDPR (green) TmDHDPR (cyan), MtDHDPR
(orange) and BhDHDPR (blue) enzymes (MUSTANG server; [27]). Residues in the nucleotide binding (NTD) and dihydrodipicolinate (DHP) binding motif are indicated by a
box. Residues at the DHP-binding motif are highly conserved, while those at the NTD-binding motif are not. In particular, residues equivalent to EcDHDPR Arg39 and Lys9 and
Lys11 of MtDHDPR (highlighted in red) are not conserved in SaDHDPR. The residues corresponding to the N-terminal and C-terminal long loop regions are highlighted in
black. Additional sequence and structural analysis is presented in Supplementary Figs. 2 and 3. (b) Analysis of sequence conservation of DHDPR enzymes in the context of the
SaDHDPR structure. This ﬁgure was made using the CONSURF server [28]. (c) Structural comparison of SaDHDPR with homologues. The structures (colors) correspond to
SaDHDPR (wheat), EcDHDPR (green), TmDHDPR (cyan) and MtDHDPR (orange) and BhDHDPR (blue). The N-terminal long loop and C-terminal long loops vary in their
conformation. The N-terminal long loop is shorter in SaDHDPR (residues Thr33 to Pro39) when compared to EcDHDPR (residues Glu40 to Gly59) and BhDHDPR (residues
Lys35 to Gly54), while it is absent in TmDHDPR and MtDHDPR. The C-terminal long loop in SaDHDPR (residues Leu157 to Pro176) is comparable to EcDHDPR (Leu182 to
Gly204) and BhDHDPR (Arg177 to Ile201). This loop is absent in TmDHDPR and adopts a different conformation in MtDHDPR.
T.S. Girish et al. / FEBS Letters 585 (2011) 2561–2567 2563The N-terminal nucleotide binding domain of SaDHDPR com-
prises residues from 1 to 103 and 214 to 240. As observed in
most DHDPR enzymes [10,11,18], this domain has a Rossmann-
fold a/b structure consisting of four a-helices and seven b-strands
(Fig. 1). The C-terminal domain of SaDHDPR comprises residues
from 108 to 211 and consists of a mixed b-sandwich formed by
two a-helices (a4-a5) and four b strands (b7-b10) (Fig. 1a andb). These eight b-strands from two adjacent DHDPR units interact
extensively with the b-strands of the opposing unit to form a six-
teen stranded central b-barrel which forms the scaffold for the
tetrameric assembly. In addition, a C-terminal long loop connect-
ing the second helix (a5) to second strand (b8) of the substrate
binding domain, provides additional strength to the tetrameric
association.
2564 T.S. Girish et al. / FEBS Letters 585 (2011) 2561–2567Despite having similar overall structure and quaternary
arrangement, SaDHDPR shows prominent differences from known
DHDPR structures [10,11,18]. A loop between b-strands (also
known as N-terminal long loop) varies from previously determined
DHDPR structures (Fig. 1c). This loop is much shorter in SaDHDPR
(residues Thr33 to Pro39) when compared to EcDHDPR (residues
Glu40 to Gly59) and B. henselae DHDPR (BhDHDPR) (residues
Lys35 to Gly54) ([12]; PDB: 3IJP). The C-terminal long loop in
SaDHDPR (residues Leu157 to Pro176) is comparable to that of
EcDHDPR (residues Leu182 to Gly204) and BhDHDPR comprising
residues Arg177 to Ile201 (Fig. 1c). This loop is absent in Tm
DHDPR [14] and adopts a different conformation in MtDHDPR [11].
3.2. Variation in the inter-domain angle of SaDHDPR monomer units
The structures of EcDHDPR and MtDHDPR determined as binary
complexes (bound to either NADH or NADPH) and ternary com-
plexes (bound to substrate analogues along with NADH or NADPH)
revealed a rotation of the N-terminal domain towards the C-termi-
nal domain upon substrate binding [10,11]. A comparison between
the crystal structures of DHDPR homologues suggests that this en-
zyme can adopt a variety of conformations due to different orien-
tations between the N-terminal and the C-terminal domain [18].
An analysis of different monomer units of SaDHDPR reveals sig-
niﬁcant differences in the orientation between the two domains.
To calculate the inter-domain angle, the angle between centre of
mass (COM) of the N-terminal domain (residues 1–103 and 214–
240), the hinge segment (Ser107 and Ser212) and the C-terminal do-
main (residue 108–211) was considered. This angle corresponds to
about 124 in case of chain C and D, while it is 117 and 113 in case
of chain A and B respectively (Fig. 2a; Supplementary Table 2). A
comparison of these orientation angles reveals that chain B of SaD-
HDPR is closer to the canonical closed conformation, chain A is par-
tially open,whereas chain C andDadopt the open conformation. It isFig. 2. Domain movements in SaDHDPR. (a) Structural superposition of the closed (ch
orientation of the two domains in the two conformers corresponds to a rotation of about
(b) The Error-inclusive Structure Comparison and Evaluation Tool (ESCET) analysis of fou
regions [21]. The lower and upper tolerance limits used were 7r and 12r. The C-termin
The N-terminal domain as a whole is ﬂexible, with regions in green being moderately ﬂimportant tonote thatnoelectrondensitywasobserved inanyof the
SaDHDPR monomer units to model either the nucleotide cofactor
(NADH or NADPH) or the substrate. The different monomer units
of SaDHDPR thus not only represent different domain orientations
but also belie the generalization that binding of both nucleotides
and substrates are essential to trigger domain re-orientation [18].
This observation is signiﬁcant as studies on the E. coli DHDPR reveal
that NADHbinding occurs in two steps, with high afﬁnity binding to
only one monomer unit. Indeed, both substrate and co-factor bind-
ing characteristics have been successfully utilized for the design of
bi-ligand inhibitors for this enzyme [20].
The conformationally ﬂexible and rigid regions of SaDHDPR
were analyzed using ESCET [21]. This analysis was performed with
the standard default parameters in this program. Except for the C-
terminal long loop region (residues Glu159 to Gln177), most of the
C-terminal domain was deﬁned as largely rigid. The N-terminal do-
main was conformationally ﬂexible with helix-a2 (Phe58 to Phe72)
and helix-a3 (residues Ala79 to Leu94) being more ﬂexible than the
rest of the regions (Fig. 2b). In addition, two segments at the inter-
domain region, residues Ser107 to Gly109 and Ser212 to Ile215
were also largely ﬂexible. Based on the ESCET analysis, it appears
likely that the entire N-terminal domain can spontaneously reori-
ent between the open and closed conformations. This ﬁnding is
consistent with that reported for MtDHDPR [18].
3.3. Nucleotide speciﬁcity of SaDHDPR
The co-factor speciﬁcity for EcDHDPR and MtDHDPR is similar-
both demonstrate a higher afﬁnity for NADH over NADPH [11,12].
TmDHDPR has a higher afﬁnity for NADPH [14]. An alignment of
SaDHDPR with other DHDPR sequences suggests minor variations
in the NAD and the DHP binding motifs (Fig. 1a; Supplementary
Fig. 2). For example, an acidic residue that is proposed to interact
with 30-OH of bound NADH (equivalent to EcDHDPR Glu38 andain B; violet) and open (chain D; teal) forms of SaDHDPR. The difference in the
11. The centers of mass of each domain in both conformers are depicted as spheres.
r chains of SaDHDPR was carried out to identify conformationally ﬂexible and rigid
al domain is conformationally invariant (blue), except for the C-terminal long loop.
exible while those in red are highly ﬂexible.
T.S. Girish et al. / FEBS Letters 585 (2011) 2561–2567 2565MtDHDPR Asp33) is conserved in SaDHDPR (Glu31). However, nei-
ther the equivalent of EcDHDPR Arg39 nor the functionally equiv-
alent Lys9 and Lys11 of MtDHDPR are conserved in SaDHDPR. This
observation was intriguing as these residues are important in
NADPH interactions in the case of the E. coli andM. tuberculosis en-
zymes [10,18]. It thus appeared likely that SaDHDPR may show aFig. 3. Thermodynamic analyses of nucleotide binding to SaDHDPR. Panels (a) and (c) re
while (b) and (d) represent NADH binding proﬁles of wild type and the K35A mutant. Eac
in the top panel, while the bottom panel shows the ﬁtted titration curve using ORIGINdistinct preference for NADH over NADPH. In order to understand
the nucleotide preference of SaDHDPR, nucleotide binding of SaD-
HDPR was monitored using isothermal titration calorimetry. In this
experiment, SaDHDPR (75 lM) in the sample cell was titrated
against either NADH or NADPH (2 mM) in separate experiments
(Fig. 3). It is pertinent to note, in this context, that the ITCpresent NADPH binding proﬁles of the wild-type and the K35A variant of SaDHDPR
h titration was performed at 75 lM protein concentration. The raw data is presented
software.
2566 T.S. Girish et al. / FEBS Letters 585 (2011) 2561–2567experiments were performed at a much higher pH (pH 7.5) when
compared to that of the crystallization buffer (pH 4.5). The Kd value
of SaDHDPR for NADH is 9.8 lM and that for NADPH is 0.9 lM. For
comparison, the reported Kd value for EcDHDPR is 0.46 lM and
2.1 lM for NADH and NADPH respectively [22].
The co-factor binding data was surprising as it could not be rec-
onciled with either sequence features or surface charge potential
differences in SaDHDPR (Fig. 4a and b). While the nucleotide bind-
ing pockets of EcDHDPR and SaDHDPR are largely similar, signiﬁ-
cant differences were seen in the N-terminal loop that connects
the second and third strands of the Rossmann fold (b2 and b3).
Probably, in order to compensate for the missing cationic residue
(Arg39 of EcDHDPR), this loop re-arranges itself such that Lys35
of SaDHDPR occupies a structurally equivalent position. In this
hypothesis, Lys35 would interact with the 20-phosphate of NADPH
(Fig. 4c; Supplementary Fig. 3). This was further experimentallyFig. 4. Cofactor speciﬁcity of SaDHDPR. Panels a and b. The surface charge potential of Ec
is represented in sticks (green) while the equivalent region of SaDHDPR is highlighted
equivalent site of SaDHDPR (wheat). Lys35 of SaDHDPR was identiﬁed as the residue equ
the 20-PO4 of NADPH.validated by the SaDHDPR K35A mutant. The K35A mutation did
not alter the oligomeric status or spectroscopic properties of SaD-
HDPR (Supplementary Fig. 4). However, NADPH binding was al-
tered by ca 20 fold in the K35A mutant enzyme, with much less
change (ca 4 fold) in NADH binding (Table 2). The structure of SaD-
HDPR provides a basis to rationalize this nucleotide preference. In-
deed, the role of Lys35 could not have been established from
sequence analysis alone as this residue is not conserved across
DHDPR homologues (Fig. 1a; Supplementary Fig. 2). On a more
general note, the nucleotide preference of SaDHDPR for NADPH
over NADH is interesting as many of the pyridine nucleotide
dependent enzymes of S. aureus including enoyl-acyl carrier pro-
tein reductase and coenzyme A-disulﬁde reductase prefer NADPH
over NADH in contrast to their E. coli homologues [23,24]. This fea-
ture could perhaps be attributed to higher NADPH/NADP+ ratios
and low NADH/NAD+ ratios in most gram-positive bacteria [25].DHDPR (a) and SaDHDPR (b) calculated using APBS [29]. Bound NADPH of EcDHDPR
. (c) A comparison of the nucleotide binding pocket of EcDHDPR (green) with the
ivalent to EcDHDPR Arg39. This residue is likely to be involved in the stabilization of
Table 2
Comparison of co-factor binding to SaDHDPR.
Ligand Protein sample Kda (lM)
NADPH WT SaDHDPR 0.9 ± 0.1
K35A SaDHDPR 20.7 ± 4.5
NADH WT SaDHDPR 9.2 ± 0.2
K35A SaDHDPR 38.0 ± 1.2
a The Kd values were determined by isothermal titration calorimetry experi-
ments. The stoichiometry (n), enthalpy (DH) and entropy (DS) are not reported as
they cannot be reliably estimated due to lack of sigmoidal binding.
T.S. Girish et al. / FEBS Letters 585 (2011) 2561–2567 2567While this manuscript was under revision, a paper reporting a sim-
ilar observation on the co-factor speciﬁcity of SaDHDPR was pub-
lished [26].
4. Conclusion
The structure of S. aureus DHDPR reveals several differences
when compared to other DHDPR homologues. The orientation be-
tween the co-factor binding and tetramerization domains exempli-
ﬁes conformational sampling and suggests the extent of domain
dynamics in this enzyme even in the absence of bound ligands.
Although SaDHDPR lacks a conserved basic residue crucial for
NADPH interaction, it exhibits a higher afﬁnity for NADPH over
NADH. A comparison of the SaDHDPR structure with EcDHDPR
suggested that a non-conserved residue in the N-terminal long
loop, Lys35, could perform the equivalent role of EcDHDPR
Arg39. The nucleotide binding characteristics of the K35A mutant
provides experimental evidence for this hypothesis. Put together,
these observations could substantially facilitate on-going pro-
grams for bi-ligand inhibitor design that relies on ligand-induced
conformational changes as well as co-factor speciﬁcity for this
important drug target.
The coordinates and structure factors for S. aureus DHDPR have
been deposited with the Protein Data Bank (PDB:3QY9).
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.febslet.2011.07.021.
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